Crossmark

The CORCOBIA study: Cut-off points of Alzheimer’s disease CSF biomarkers in a clinical cohort

Crossref DOI link: https://doi.org/10.1016/j.nrleng.2022.05.002

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Puig-Pijoan, A.

García-Escobar, G.

Fernández-Lebrero, A.

Manero-Borràs, R.M.

Sánchez-Benavides, G.

Navalpotro-Gómez, I.

Cascales Lahoz, D.

Suárez-Calvet, M.

Grau-Rivera, O.

Boltes Alandí, A.

Pont-Sunyer, M.C.

Ortiz-Gil, J.

Carrillo-Molina, S.

López-Villegas, D.

Abellán-Vidal, M.T.

Martínez-Casamitjana, M.I.

Hernández-Sánchez, J.J.

Peña-Casanova, J.

Roquer, J.

Padrós Fluvià, A.

Puente-Périz, V.
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2022-08-09
More Information

This article is maintained by: Elsevier

Article Title: The CORCOBIA study: Cut-off points of Alzheimer’s disease CSF biomarkers in a clinical cohort

Journal Title: Neurología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nrleng.2022.05.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nrl.2022.05.005

Content Type: article

Copyright: © 2022 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.